These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

593 related items for PubMed ID: 15305413

  • 1. Postoperative serum carcinoembryonic antigen levels in patients with pathologic stage IA nonsmall cell lung carcinoma: subnormal levels as an indicator of favorable prognosis.
    Sawabata N, Maeda H, Yokota S, Takeda S, Koma M, Tokunaga T, Ito M.
    Cancer; 2004 Aug 15; 101(4):803-9. PubMed ID: 15305413
    [Abstract] [Full Text] [Related]

  • 2. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer.
    Hsu WH, Huang CS, Hsu HS, Huang WJ, Lee HC, Huang BS, Huang MH.
    Ann Thorac Surg; 2007 Feb 15; 83(2):419-24. PubMed ID: 17257963
    [Abstract] [Full Text] [Related]

  • 3. Persistently high serum carcinoembryonic antigen levels after surgery indicate poor prognosis in patients with stage I non-small-cell lung cancer.
    Wang CY, Huang MS, Huang MH, Lee HC, Hsu HS.
    J Surg Res; 2010 Oct 15; 163(2):e45-50. PubMed ID: 20638687
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
    Matsuoka K, Sumitomo S, Nakashima N, Nakajima D, Misaki N.
    Eur J Cardiothorac Surg; 2007 Sep 15; 32(3):435-9. PubMed ID: 17611117
    [Abstract] [Full Text] [Related]

  • 5. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
    Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A, Tsubota N.
    Ann Thorac Surg; 2004 Sep 15; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
    [Abstract] [Full Text] [Related]

  • 6. The prognostic value of carcinoembryonic antigen in T1N1M0 and T2N1M0 non-small cell carcinoma of the lung.
    Fukai R, Sakao Y, Sakuraba M, Oh S, Shiomi K, Sonobe S, Saitoh Y, Miyamoto H.
    Eur J Cardiothorac Surg; 2007 Sep 15; 32(3):440-4. PubMed ID: 17643308
    [Abstract] [Full Text] [Related]

  • 7. Pathologic stage I non-small cell lung cancer with high levels of preoperative serum carcinoembryonic antigen: clinicopathologic characteristics and prognosis.
    Matsuguma H, Nakahara R, Igarashi S, Ishikawa Y, Suzuki H, Miyazawa N, Honjo S, Yokoi K.
    J Thorac Cardiovasc Surg; 2008 Jan 15; 135(1):44-9. PubMed ID: 18179917
    [Abstract] [Full Text] [Related]

  • 8. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W, Stieber P, Reuter C, Nagel D, Lau-Werner U, Lamerz R.
    Anticancer Res; 2000 Jan 15; 20(6D):5195-8. PubMed ID: 11326694
    [Abstract] [Full Text] [Related]

  • 9. Characteristics and prognosis of patients after resection of nonsmall cell lung carcinoma measuring 2 cm or less in greatest dimension.
    Okada M, Sakamoto T, Nishio W, Uchino K, Tsubota N.
    Cancer; 2003 Aug 01; 98(3):535-41. PubMed ID: 12879471
    [Abstract] [Full Text] [Related]

  • 10. Carcinoembryonic antigen as a predictive factor for postoperative tumor relapse in early-stage lung adenocarcinoma.
    Sakao Y, Tomimitsu S, Takeda Y, Natsuaki M, Itoh T.
    Eur J Cardiothorac Surg; 2004 Apr 01; 25(4):520-2. PubMed ID: 15037265
    [Abstract] [Full Text] [Related]

  • 11. Increased CYFRA 21-1 and CEA levels are negative predictors of outcome in p-stage I NSCLC.
    Muley T, Dienemann H, Ebert W.
    Anticancer Res; 2003 Apr 01; 23(5b):4085-93. PubMed ID: 14666606
    [Abstract] [Full Text] [Related]

  • 12. Clinical significance of preoperative carcinoembryonic antigen level for clinical stage I non-small cell lung cancer: can preoperative carcinoembryonic antigen level predict pathological stage?
    Kawachi R, Nakazato Y, Takei H, Koshi-ishi Y, Goya T.
    Interact Cardiovasc Thorac Surg; 2009 Aug 01; 9(2):199-202. PubMed ID: 19457896
    [Abstract] [Full Text] [Related]

  • 13. Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small cell lung cancer.
    Gaspar MJ, Diez M, Rodriguez A, Ratia T, Martin Duce A, Galvan M, Granell J, Coca C.
    Anticancer Res; 2003 Aug 01; 23(4):3427-32. PubMed ID: 12926084
    [Abstract] [Full Text] [Related]

  • 14. Prognostic determinants for lung cancer patients with preoperative high serum carcinoembryonic antigen levels.
    Tomita M, Matsuzaki Y, Shimizu T, Hara M, Ayabe T, Onitsuka T.
    Thorac Cardiovasc Surg; 2005 Oct 01; 53(5):300-4. PubMed ID: 16208617
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer.
    Hotta K, Segawa Y, Takigawa N, Kishino D, Saeki H, Nakata M, Mandai K, Eguchi K.
    Anticancer Res; 2000 Oct 01; 20(3B):2177-80. PubMed ID: 10928173
    [Abstract] [Full Text] [Related]

  • 16. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R, Fujii S, Ohta M, Nagano Y, Kunisaki C, Yamagishi S, Osada S, Ichikawa Y, Shimada H.
    Ann Surg Oncol; 2008 Dec 01; 15(12):3433-9. PubMed ID: 18846401
    [Abstract] [Full Text] [Related]

  • 17. CYFRA 21-1 and CEA are independent prognostic factors in 153 operated stage I NSCLC patients.
    Muley T, Dienemann H, Ebert W.
    Anticancer Res; 2004 Dec 01; 24(3b):1953-6. PubMed ID: 15274383
    [Abstract] [Full Text] [Related]

  • 18. Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma.
    Ardizzoni A, Cafferata MA, Paganuzzi M, Filiberti R, Marroni P, Neri M, Fontana V, Nicoló G, Perdelli L, Stampino CG, Rosso R, Puntoni R.
    Cancer; 2001 Oct 01; 92(7):1896-904. PubMed ID: 11745263
    [Abstract] [Full Text] [Related]

  • 19. Analysis of the prognostic significance of cytosolic determination of CA 125 tumor-associated antigen, carcinoembryonic antigen and squamous cell carcinoma antigen in patients with nonsmall cell lung carcinoma.
    Picardo AL, Diez M, Torres A, Maestro M, Ortega D, Hernando F, Gómez A, Garcia-Asenjo J, Balibrea JL.
    Cancer; 1996 Mar 15; 77(6):1066-72. PubMed ID: 8635125
    [Abstract] [Full Text] [Related]

  • 20. Tumour CEA as predictor of better outcome in squamous cell carcinoma of the lung.
    Veronesi G, Pelosi G, Sonzogni A, Leon ME, D'Aiuto M, Gasparri R, De Braud F, De Pas T, Sandri M, Spaggiari L.
    Lung Cancer; 2005 May 15; 48(2):233-40. PubMed ID: 15829323
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.